Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
24,592,670
-
Share change
-
-391,404
-
Total reported value
-
$3,349,074,589
-
Put/Call ratio
-
172%
-
Price per share
-
$136.15
-
Number of holders
-
284
-
Value change
-
-$39,913,004
-
Number of buys
-
159
-
Number of sells
-
98
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2017
As of 30 Sep 2017,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
284 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,592,670 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, STATE STREET CORP, Knott David M, JANUS HENDERSON GROUP PLC, VICTORY CAPITAL MANAGEMENT INC, CARDINAL CAPITAL MANAGEMENT LLC /CT, and FMR LLC.
This page lists
286
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.